1. No category

All-Ireland Cancer Consortium Conference
“New horizons in cancer - removing boundaries”
Sunday 10th May – 13th May 2015
Saturday 9th
May
Location
Time
Programme
Centre for Cancer Research & Cell Biology - Open Day
CCRCB
Building
1100-1500
Location
Time
Programme
1600-1800
(Combined Conference 1 / 2 (C1 & C2))
Talks, Lab Tours, Interactive Activities – ALL WELCOME
Reclaiming life after cancer
Riddell Hall
Sunday
10th May
Coordinated by: Heather Monteverde (Macmillan) and Olwyn Ryan (Irish Cancer Society)
1620-1630
Ian Banks President European Men's Health Forum and Chair of the ECCO Patient Advocacy Committee: Opening Remarks:
1630-1650
Julia Rowland, Director, Office of Cancer Survivorship NCI, US: The changing landscape of cancer
1650-1700
The survivorship story: Short video /animation
1700-1800
1800-1830
1830-1855
1855-1900
1900-2000
Living with and beyond cancer – exploring the issues
Capturing the learning
Facilitated table discussions & Feedback on main themes
Expert Panel Discussion on issues raised

Psychologist

Oncologist

Surgeon

General Practitioner

Public Health Consultant

Cancer Nurse Consultant
Christy Kenneally: Teamwork in cancer – who is in the team??
Ian Banks: Closing Remarks
Reception and Cancer Choirs
0830-1730
AICC PLENARY SESSION
(Combined Conference 1 / 2)
Opening Session
Dr Tony Holohan (ROI); Dr Michael McBride (NI); Dr Ted Trimble (NCI)
0830- 0920
Riddell Hall
1010-1050
Coffee / Tea (Isdell)
Posters (Glass Corridor)
1050-1140
Population health/ cancer prevention / health promotion: Keynote Speaker
Dr Gauden Galea: Director of Non Communicable Diseases and Health Promotion, WHO Regional office for Europe
1140-1230
Palliative care / end of life: Keynote Speaker
Prof Declan Walsh (Professor in Palliative Medicine), TCD, Ireland
“Interface of palliative care and oncology”
1230-1325
Lunch / exhibition (Isdell)
Posters (Glass Corridor)
1325-1435
1435-1525
Belfast
City
Hall
Monday 11th May
0920-1010
Reflections: 15th Anniversary of the AICC –
Lee Helman, Paddy Johnston (QUB), Speaker TBC (ROI)
Capacity Building – the vision: Keynote Speaker
Alexander Eggermont: (Directeur Général Gustave Roussy, Paris)
“Cancer Core Europe”
“Innovation in cancer health care – time to grasp the nettle”
Chair: Colette Goldrick, Director ABPI Northern Ireland
Omid Vafa, Oncology and Biotechnology Innovation leader Global J&J Innovation Centre London
David Waugh, Centre for Cancer Research and Cell Biology, QUB
Ian Banks, President European Men’s Health Forum and Chair ECCO Patient Advocacy Committee
Cancer Nursing Research: Keynote Speaker
Professor Nora Kearney: Professor of Cancer Nursing, University of Surrey.
“Evaluation of the impact of Advanced Symptom Management System (ASyMS)”
1525-1555
Coffee / Tea (Isdell)
Posters (Glass Corridor)
1555-1645
Survivorship: Keynote Speaker(s)
Julia Rowland, Director, Office of Cancer Survivorship NCI, US
1645-1730
Round Table Wrap-up
Facilitated (Peter Cardwell (UTV)) feedback and questions to panel from Patients & Charities Forum
1900-2400
Welcome reception and dinner
Date
Location
Time
A1. Genetic basis /
stratification
B1. Cancer Epidemiology
& Surveillance of Cancer
Torsten Hafelach
(Munich): “Molecular
stratification in myeloid
leukaemia”
Proposed Chair: Dr Anna
Gavin (QUB)
Charlie Gourley
(Edinburgh): “ICON 7”
0830–1030
B: Population health/
cancer prevention
/health promotion
A: Cancer Research /
CCRCB symposium
Ronnie Drapkin (Harvard):
“Pathology and basic
biology)”
Riddell Hall
Tuesday 12th May
0900-1700
Programme
Work Stream specific sessions
David Grimwade (GKT,
London) “Molecular
monitoring in AML”
Former NCI fellows:


Dr Sharon Glynne
(NUI. Galway)
Dr Lesley Anderson
(QUB)
Harry Comber (Cancer
Registry): “What we know
now about cancer on the
Island since the
NCI/Ireland/N. Ireland
consortium”
Robert Hoover (Division
Cancer Epidemiology &
Genetics, Epidemiology
and Biostatistics Program,
NCI) “Health Promotion
and Control of Risk
Factors”
C: Survivorship
C1.
Dr Robert Glynne-Jones,
Mount Vernon Centre
for Cancer Treatment,
“Is adherence to cancer
treatment a problem?”
Professor Kader
Parahoo, Institute of
Health & Nursing
Research, UU: “The
challenges of evaluating
the effectiveness of
psychosocial
interventions for people
with cancer”
Dr Colin McCowan,
Reader in Health
Informatics (Robertson
Centre for Biostatistics),
University of Glasgow:
“Woman, breast cancer
and Tamoxifen”
2 x Selected Abstracts
2 x Selected Abstracts
1030-1100
Coffee / Tea (Isdell)
Posters (Glass Corridor)
D: Palliative care /
End of life
D1. Symptom
Management
Professor Lukas Radbruch
/ Professor Jane Seymour:
“Palliative sedationdebate”?
Professor Declan Walsh
(TCD)” Cancer Cachexia”
Prof David Meagher (UL):
“Managing delirium/
cognitive impairment”
Mike Lucey/Sarah Mclean
(Clinical Care
Programme): “Cancer pain
guidelines: a protocol for
accessing the evidence
confirmed”
E: Cancer Nursing Research
E1. Cancer Nursing Research
Eileen Furlong, UCD: “How a
Maternal Cancer Diagnosis
Affects the Children”
Rachel Smith, Family Centre
Cancer Care: The Way Forward
Carla O Neill, UU: “Cancer and
Fatherhood: A
phenomenological study of
paternal experiences when
diagnosed and living with the
illness”
2 x Selected Abstracts
A2. Hallmarks of Cancer I
Margaret Frame
(Edinburgh): “SRC biology
of invasion”
Simone Fulde (Frankfurt)
“Modulation of Apoptosis”
Ian Mills (QUB) “Hormonal
Control of metabolism
Selected Abstracts:
1100-1245
Catriona Holohan (QUB)
Identification of novel
regulators of FLIP
ubiquitination
Gareth Irwin (QUB) SF3B1
mutation as a predictor of
BRCAness in ER positive
breast cancer
B2. Health Promotion and
Control of Risk Factors
Proposed Chair: Stephanie
O’Keefe, Health &
Wellbeing, HSE
Susan Michie
(Department of Clinical,
Educational and Health
Psychology, University
College London)
“Behaviour change”
Skin cancer prevention
North & South – brief
presentations followed by
panel discussion (NI:
Dervilia Kernaghan,
Miriam McCarthy; RoI:
Barbara McGrogan,
Rosemary Scott)
Mary Murphy (UU)
“Investigating the
decision making process
in patients with noncurative cancer who
have been invited to join
a clinical research trial”
Dr Cherith Semple,
Ulster Hospital “Posttreatment follow-up for
patients with head and
neck cancer”
D2. Psychosocial;
communication and
information
Dr Susie Wilkinson,
“Advanced
communication”
Professor Kevin Brazil
(QUB) “Advanced care
planning/decision making
for end of life care”
Prof Phil Larkin (UCD)
“Compassion in oncology
TX setting”
Louise Mullen, National
Cancer Control
Programme, Dublin
“Survivorship Care Plan –
National Cancer Control
Programme”
A3. Clinical Trials
Chair: Richard Wilson
(QUB)
Tim Maugham, Oxford:
FOCUS 4
Sandra van Schaeybroeck,
QUB: Mercuric
Rebecca Fitzgerald,
Cambridge
Ray McDermott, Dublin
Ruth Boyd and Margaret
Grayson (NI Cancer
Research Consumer
Forum)
B3. Cancer Awareness &
Early Diagnosis
Proposed Chair: Ian
Banks, European Men’s
Healthcare Forum
Anna Gavin (QUB)
International Cancer
Benchmarking Partnership
Gerry McElwee/Dervilia
Kernaghan (Cancer Focus
NI): “‘well aware’
programme”
Eileen Nolan (NCCP)
Selected Abstract:
2 x Selected Abstracts
1 Poster – Oral (5:3:2
format)
Additional speakersTBC
C3. Survivorship/
Nursing joint short
presentations
E2.
Dr Janice Richmond,
Letterkenny Hospital: “To
explore Irish patients
knowledge and perception of
their lifestyle risk factors for
cancer in Ireland, compare
these with international
counterparts, explore these
patients motivation for change
with regard to health
behaviour and ultimately
develop an app as a patient
information educational tool”
Professor Josephine Hegarty,
UUC: “Experience of individuals
who live with, through and
beyond cancer in Ireland.”
Dr Gillian Prue, QUB: “Needs
assessment and subsequent
interventions for informal
cancer caregivers”
Lunch / exhibition (Isdell)
Posters (Glass Corridor)
1230-1330
1330-15.15
C2:
D3. Assessment,
measurement, research
Methodology/ & public
health
7 x Selected Abstracts
Dr S McIlfatrick (Ulster),
Methodological challenges
and strategies associated
with palliative care
research
Professor Charles
Normand (TCD), Health
economics of palliative
care
Dr Deirdre Fitzpatrick
(Cancer Registry)
Qualycare study inform
policy
Ruth Boyd and Margaret
Grayson (NI Cancer
Research Consumer
Forum) Personal and
Public Involvement (PPI) in
Cancer Research – the
Northern Ireland Model
1515-1545
Coffee / Tea (Isdell)
Posters (Glass Corridor)
G1. Addressing the Cancer Challenge – Policy and Action
Facilitated by Mariam McCarthy (PHA, NI) and Mark Lawler (QUB)
Sean Duffy (National Cancer Director, NHS England)
1545-1715
Richard Sullivan (Kings College London) “Cancer Policy and Global Health”
Magda Chlebus (Director of Science Policy EFPIA)
“Placing Europe at the centre of a 21st century Precision Medicine Revolution; opportunities and challenges”
Jerome Coffey (ROI)
Additional Speaker TBC
1715-1830
H. Poster session and canapés / refreshments
Date
Location
Time
Programme
Work Stream
(continued)
Satellite Symposium
Satellite Symposium
A: CCRCB symposium
F: Quantitative
Biology
I: Maximising the value
of cancer care and
research
0830-1700
A4. Hallmarks of Cancer
II
I1. “Improving cancer
outcomes – bending the
cancer cost curve”
Tracy Robson (QUB)
Corrado Santocanale
(NIUG)
Adrien Bracken (Dublin)
Riddell Hal
Wednesday 13th May
“DNA replication and the
cell cycle”
“Roles of Polycomb –like
Proteins in p53 Control,
Cellular Senescence and
Quiescence”
0830-1030
Selected Abstracts:
Barbara McGrogan
(National Cancer Control
Programme, Dublin)
Spindle assembly
checkpoint protein
expression correlates with
cellular proliferation and
shorter time to
recurrence in ovarian
cancer
Amy Templeman (QUB):
TBX2 drives breast cancer
pathogenesis through
repression of Cystatin 6
and activation of LGMN
signalling
1030-1100
F1.
Mario Albrecht
Graz University of
Technology, Austria
Andrew Harrison
University of Essex
Darragh McArt
Queen’s University
Belfast, UK
Selected Abstract:
Kathryn Clarke (QUB)
Integrated analysis of
both biological and
molecular effects of the
epigenetic modifying
agent Romidepsin in
MDS/AML
Chairs: (TBC)
Richard Sullivan, Institute
of Cancer Policy Kings
College London
Mark Lawler, Centre for
Cancer Research and Cell
Biology, QUB
“Shaping improved
outcomes for Europe’s
citizens in an era of
economic austerity”
Janice Walshe
AMNCH/St Vincents
“Stratifying breast cancer
patients using molecular
tests - maximising both
quality care and cost
effectiveness”
Stephen Whitehead,
ABPI
Additional Speakers TBC
Coffee / Tea / Posters (Glass Corridor)
F2
Chair: Shu-Dong Zhang
(QUB)
A5: Imaging Workshop
1100-1230
Gabri van der Pluijm
(Leiden) “Real Molecular
Imaging”
Ricardo de Matos Simoes
Queen’s University
Belfast, UK
Henry Charles Manning
(Vanderbilt): “PET probe
based cell imaging”
David Westhead
University of Leeds, UK
Denis Shields
University College Dublin
Gerry Hanna (QUB):
“Stereotactic Ablative
Radiotherapy, a new
weapon against
advanced disease”
1230-1330
Selected Abstract:
Simon McDade (QUB)
“Genome wide
characterization reveals
complex interplay
between TP53 and TP63
in response to genotoxic
stress.”
Ultan McDermott, Sanger
Tim Davidson, Almac
Additional Speaker TBC
1500-1530
Dr Mary Dallat (QUB)
Selected Abstract:
Marie Bradley (NCI,
USA): “Potentially
inappropriate medication
use in older people: a
study in the Prostate,
Lung, Colorectal and
Ovarian Cancer Screening
cohort (PLCO)”
Lunch / Posters (Glass Corridor)
A6: Genetics Workshop
1330-1500
I2. “Improving cancer
outcomes – bending the
cancer cost curve”
Coffee / Tea / Posters
(Glass Corridor)
A7: Poster Discussion
Session
Cheryl McFarlane (QUB)
“Development of In Cell
Western Screen to identify
novel target of the
Ubiquitin Proteasome
system which regulate
‘undruggable’ transcription
factors”
Niamh McGivern (QUB)
“Mechanisms of Resistance
to the SRC Inhibitor
Saracatinib in Ovarian
Cancer”
1530-1600
Maeve Mullooly (NCI,
USA) “The relationship
between crown-like
structures and adipose
tissue hormone levels
among postmenopausal
women with breast cancer”
James Beirne (QUB) “A
New Primary Prevention
Strategy for High Grade
Serous "Ovarian"
Carcinoma.”
Richard Turkington (QUB)
“Association of a DNA
Damage Response
Deficiency (DDRD) assay
and prognosis in early
stage Oesophageal
Adenocarcinoma”
1600-1630
A8: Keynote: Steve
Channock, NCI